Business
Leveljump Closes Acquisition of 23.8% Interest in Shaw Lens and Shaw Vision
Toronto, Ontario--(Newsfile Corp. - September 15, 2021) - Leveljump Healthcare Corp. (TSXV: JU...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"Leveljump Closes Acquisition of 23.8% Interest in Shaw Lens and Shaw VisionToronto, Ontario--(Newsfile Corp. - September 15, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (\"Leveljump\" or the \"Company\"), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has closed its acquisition of 23.8% of the issued and outstanding shares of each of Shaw Vision Inc. (\"Shaw Vision\") and Shaw Lens Inc. (\"Shaw Lens\") from a minority shareholder (the \"Shaw Acquisition\"), as originally announced on August 31, 2021.The Shaw Acquisition has been approved by the boards of Shaw Vision and Shaw Lens. Closing of the Shaw Acquisition and has received final consent of the TSX Venture Exchange.All securities issued will be subject to a hold period of four months and one day pursuant to applicable securities laws.Both Shaw Vision Inc. and Shaw Lens Inc. are Toronto-based privately owned federal corporations.About Shaw Lens and Shaw VisionShaw Lens holds a U.S. patent protected lens technology that can solve a condition for people who wear glasses, known as aniseikonia. It is a condition that causes each eye to perceive the size of objects differently. Issues related can include headaches, double vision, disorientation or dizziness, tearing, eye pain or fatigue, sensitivity to light, visual acuity issues and trouble reading, as well as nausea…according to the Columbia University Department of Ophthalmology… \"20-30% of the general spectacle wearing population may have a measurable amount of aniseikonia.\" The potential market size for corrective lenses for aniseikonia is over 800 million people that may be currently living with some degree of aniseikonia and its relative effects. More information about Shaw can be found at www.shawlens.com.About Leveljump HealthcareLeveljump Healthcare Corp., (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.ON BEHALF OF THE BOARD OF DIRECTORS OFLEVELJUMP HEALTHCARE CORP.Mitchell Geisler, Chief Executiv...